Kislinger, Thomas

8 records totalling $2,680,805.00 CAD, from official Government of Canada open data.

Embed this chart

By department

Canadian Institutes of Health Research $2,680,805 8 records

Records

Kislinger, Thomas $504,901.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Investigator-Initiated Research
FY 2020-2021
Canada

The Project Grant program is expected to: • Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercia...

KISLINGER, Thomas $500,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2011-2012
Canada

CANADA RESEARCH CHAIRHOLDER / TITULAIRE DE CHAIRE DE RECHERCHE DU CANADA

KISLINGER, Thomas $437,079.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2011-2012
Canada

A Systematic Proteomic Analysis Strategy for Biomarker Discovery in Head & Neck Cancer

KISLINGER, Thomas $351,553.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2014-2015
Canada

A Novel Biomarker Discovery Strategy Combining Primary Tumour Xenograft Models and Glyco-Capture of Secreted Proteins

KISLINGER, Thomas $346,847.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2012-2013
Canada

Biomarkers for the detection of aggressive prostate cancers: Application of targeted proteomics to clinically stratified expressed prostatic secretions and urines

Kislinger, Thomas $340,425.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2018-2019
Canada

Proteogenomics Panorama of Localized Prostate Cancers

Kislinger, Thomas $100,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2016-2017
Canada

Molecular Analyses of the Intercalated Disc Protein Tmem65 as a Novel Regulator of Cardiac Communication

Kislinger, Thomas $100,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2018-2019
Canada

Identifying the molecular landscape of the triple negative breast cancer cell surface proteome – an avenue for new therapies